复苏期间的胺 - 它是否像我们想象的那样在血液动力学上是完美的?
Steven G Schauer1, Michael D April2, Allyson A Arana3
1Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA; Departments of Anesthesiology and Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA; Center for Combat and Battlefield (COMBAT) Research, University of Colorado School of Medicine, Aurora, Colorado, USA.
The American journal of emergency medicine
|September 10, 2023
概括
在创伤患者中使用胺可能不会改善组织的氧气输送,尽管增加了标准的生命体征,如血压和心率. 需要进一步的研究来了解胺.
科学领域:
- 创伤复苏的复苏治疗方法
- 麻醉学 麻醉学
- 关键护理医学 关键护理医学
背景情况:
- 胺通常被认为对低血压患者具有有利的血液动力学特征.
- 补偿储备测量 (CRM) 算法跟踪系统氧气供应的充分性 (DO2).
研究的目的:
- 用CRM调查凯胺对创伤患者的DO2的影响.
- 为了评估胺胺除了标准生命体征之外的血液动力学影响.
主要方法:
- 对符合主要激活标准的创伤患者进行前性研究.
- 收集了生命体征和动脉波形数据.
- 追踪干预和血液动力学参数,包括SBP,MAP和HR.
主要成果:
- 8名创伤患者接受了胺 (20-300毫克) 用于输管或止痛.
- 随着胺,SBP,MAP和HR的增加.
- CRM显示变化最小,表明DO2.2没有显著改善.
结论:
- 标准生命体征 (SBP,MAP,HR) 在服用胺后增加.
- 尽管有明显的血液动力学改善,但胺可能不会增强组织的氧气输送 (DO2).
- 进一步调查胺对血液动力学和DO2的影响是有必要的.
相关概念视频
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
17
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
17
01:24Parenteral Anesthetics: Overview
154
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
154